Results 161 to 170 of about 12,135 (209)

Self and parasite-derived peptides selected upon DERAA-bearing HLA-DRB1 alleles activate CD4+ T cells from Chagas cardiomyopathy patients and are associated with ventricular dysfunction. [PDF]

Front Immunol
Souza-Silva TG, Neves EGA, Teixeira-Carvalho A, Figueiredo AB, Morais KLP, Apostólico J, Rodrigues H, Kalil J, Juliano MA, Juliano L, Araújo SS, Pantaleao AN, Mutarelli A, Nunes MCP, Gollob KJ, Dutra WO.   +15 more
europepmc   +1 more source

Unraveling the role of miRNAs as biomarkers in Chagas cardiomyopathy: Insights into molecular pathophysiology. [PDF]

PLoS Negl Trop Dis
Ribeiro HG, Galdino OA, de Souza KSC, Rosa Neta AP, Lin-Wang HT, Cunha-Neto E, Rezende AA, Silbiger VN.   +7 more
europepmc   +1 more source

Adipocyte-released adipomes in Chagas cardiomyopathy: Impact on cardiac metabolic and immune regulation. [PDF]

iScience
Thangavel H, Dhanyalayam D, Kim M, Lizardo K, Sidrat T, Lopez JG, Wang X, Bansal S, Nagajyothi JF.   +8 more
europepmc   +1 more source

Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical Trial.

JAMA Cardiol
Martinelli-Filho M, Marin-Neto JA, Scanavacca MI, de Paola AAV, Medeiros PTJ, Owen R, Pocock SJ, de Siqueira SF, CHAGASICS investigators.   +8 more
europepmc   +1 more source

Factors influencing the use of direct oral anticoagulants among patients with chronic chagas cardiomyopathy. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Gómez-Ochoa SA, Rojas LZ, Alarcón Meléndez LJ, Quintero Santana MA, Becerra-Motta LP, Serrano-García AY, Echeverría LE.   +6 more
europepmc   +1 more source

Assessment of Plasma Exovesicles and Prothrombotic Biomarkers Suggest Prethrombotic Conditions in Chagas Cardiomyopathy in Colombia. [PDF]

Clin Appl Thromb Hemost
Jaimes-Dueñez JE, Álvarez K, Eduardo-Echeverria L, Cáceres-Rivera DI, Rojas LZ, Gómez-Ochoa SA, Daniela-Muñoz L, Cantillo-Reines M, Tique-Oviedo M, Eresbey-Granada Y, Triana-Chávez Biol O.   +10 more
europepmc   +1 more source

Chagas cardiomyopathy in Boston, Massachusetts: Identifying disease and improving management after community and hospital-based screening. [PDF]

PLoS Negl Trop Dis
Reifler KA, Wheelock A, Hall SM, Salazar A, Hassan S, Bostrom JA, Barnett ED, Carrion M, Hochberg NS, Hamer DH, Gopal DM, Bourque D.   +11 more
europepmc   +1 more source

Correlation of blood-based immune molecules with cardiac gene expression profiles reveals insights into Chagas cardiomyopathy pathogenesis. [PDF]

Front Immunol
Souza-Silva TG, Neves EGA, Koh C, Teixeira-Carvalho A, Araújo SS, Nunes MDCP, Gomes JAS, Gollob KJ, Dutra WO.   +8 more
europepmc   +1 more source

Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial. [PDF]

Sci Rep
Vieira MC, Mendes FSNS, da Silva PS, da Silva GMS, Mazzoli-Rocha F, de Sousa AS, Saraiva RM, de Holanda MT, Kasal DAB, Costa HS, Borges JP, Reis MS, Rodrigues Junior LF, Hasslocher-Moreno AM, do Brasil PEAA, Mediano MFF.   +15 more
europepmc   +1 more source

Emerging Trends in Left Ventricular Thrombus: A Comprehensive Review of Non-Ischemic and Ischemic Cardiopathies, Including Eosinophilic Myocarditis, Chagas Cardiomyopathy, Amyloidosis, and Innovative Anticoagulant Approaches. [PDF]

Diagnostics (Basel)
Colle B, Demeure F, Higny J, Benoit M, Henry JP, Michaux I, Robaye B, Xhaët O, Gabriel L, Guedes A, Blommaert D, Dulieu N, Berners Y, Wery F, Droogmans S, Cosyns B, Luchian ML.   +16 more
europepmc   +1 more source